Treatment sequences and survival outcomes in advanced HR + HER2- breast cancer patients: a real-world cohort.

Breast Cancer Res Treat · 2025 · PMC11787233 · PMID 39508972

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, OS of patients on tamoxifen was considerably longer than the OS of all other groups, although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.